SpringWorks Therapeutics, Inc. (SWTX)
USD 46.23
(0.04%)
USD 46.23
(0.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -341.34 Million USD | -21.62% |
| 2022 | -280.67 Million USD | -62.26% |
| 2021 | -172.97 Million USD | -276.24% |
| 2020 | -45.97 Million USD | 22.14% |
| 2019 | -59.04 Million USD | -219.62% |
| 2018 | -18.47 Million USD | -296.71% |
| 2017 | -4.63 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -44.07 Million USD | 52.71% |
| 2024 Q1 | -93.2 Million USD | 4.82% |
| 2023 Q3 | -83.5 Million USD | -0.79% |
| 2023 Q2 | -82.85 Million USD | -6.98% |
| 2023 FY | - USD | -21.62% |
| 2023 Q1 | -77.44 Million USD | 0.96% |
| 2023 Q4 | -97.92 Million USD | -17.27% |
| 2022 Q4 | -78.19 Million USD | -9.33% |
| 2022 Q3 | -71.52 Million USD | -3.93% |
| 2022 Q2 | -68.82 Million USD | -12.16% |
| 2022 Q1 | -61.36 Million USD | -10.26% |
| 2022 FY | - USD | -62.26% |
| 2021 FY | - USD | -276.24% |
| 2021 Q1 | -29.64 Million USD | -361.68% |
| 2021 Q3 | -40.77 Million USD | 13.07% |
| 2021 Q4 | -55.65 Million USD | -36.48% |
| 2021 Q2 | -46.9 Million USD | -58.22% |
| 2020 FY | - USD | 22.14% |
| 2020 Q4 | 11.32 Million USD | 152.7% |
| 2020 Q1 | -16.06 Million USD | 7.2% |
| 2020 Q2 | -19.74 Million USD | -22.96% |
| 2020 Q3 | -21.49 Million USD | -8.86% |
| 2019 Q4 | -17.3 Million USD | -13.36% |
| 2019 FY | - USD | -219.62% |
| 2019 Q3 | -15.26 Million USD | -3.09% |
| 2019 Q2 | -14.8 Million USD | -26.92% |
| 2019 Q1 | -11.66 Million USD | -81.19% |
| 2018 Q1 | -3.4 Million USD | 0.0% |
| 2018 Q2 | -3.4 Million USD | 0.0% |
| 2018 Q3 | -5.22 Million USD | -53.55% |
| 2018 Q4 | -6.43 Million USD | -23.19% |
| 2018 FY | - USD | -296.71% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Absci Corporation | -95.45 Million USD | -257.591% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -80.346% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -32.181% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3352.506% |
| Apollomics, Inc. | -171.74 Million USD | -98.749% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1442.178% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -988.684% |
| Bicycle Therapeutics plc | -183.4 Million USD | -86.121% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -356.254% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -106.35% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1484.781% |
| Chimerix, Inc. | -92.97 Million USD | -267.141% |
| CRISPR Therapeutics AG | -202.7 Million USD | -68.399% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1548.038% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -394.697% |
| Fortress Biotech, Inc. | -133.64 Million USD | -155.416% |
| Fortress Biotech, Inc. | -133.64 Million USD | -155.416% |
| Gritstone bio, Inc. | -126.86 Million USD | -169.067% |
| Allakos Inc. | -189.91 Million USD | -79.736% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -604.14% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -190.137% |
| Cytokinetics, Incorporated | -456.68 Million USD | 25.256% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -260.176% |
| Innoviva, Inc. | 248.96 Million USD | 237.109% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -222784.903% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2793.828% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -171.241% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2649096.074% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -233.782% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -285.846% |
| ImmuCell Corporation | -2.5 Million USD | -13531.61% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -161.726% |
| Incyte Corporation | 919.42 Million USD | 137.126% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -161.786% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5243.028% |
| Mustang Bio, Inc. | -48.06 Million USD | -610.205% |
| MiMedx Group, Inc. | 40.51 Million USD | 942.476% |
| MEI Pharma, Inc. | 26.38 Million USD | 1393.958% |
| MacroGenics, Inc. | 2.01 Million USD | 17023.451% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 79660.599% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1210.048% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -2794.658% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -171.995% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 147.914% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1473.645% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2049.534% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3110.251% |
| NextCure, Inc. | -59.03 Million USD | -478.17% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -566.444% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3324.418% |
| Onconetix, Inc. | -36.7 Million USD | -829.928% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 15372.752% |
| Opthea Limited | -200.01 Million USD | -70.657% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -481.379% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -12305.454% |
| PDS Biotechnology Corporation | -40.08 Million USD | -751.556% |
| Precigen, Inc. | -89.22 Million USD | -282.563% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1399.631% |
| Prime Medicine, Inc. | -193.75 Million USD | -76.17% |
| PureTech Health plc | -11.62 Million USD | -2835.805% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -44.258% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 107.334% |
| Replimune Group, Inc. | -230.19 Million USD | -48.284% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -358426.594% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -1910.164% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1799.168% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 20.725% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1315.674% |
| Sesen Bio, Inc. | -50.84 Million USD | -571.412% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -290.435% |
| Solid Biosciences Inc. | -93.43 Million USD | -265.334% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -48.449% |
| SciSparc Ltd. | -5.28 Million USD | -6362.438% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -402.608% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1407.839% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -199.193% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -4664.075% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -4.628% |
| UroGen Pharma Ltd. | -63.83 Million USD | -434.765% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -448.814% |
| XOMA Corporation | -39.36 Million USD | -767.197% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -23.899% |
| AbCellera Biologics Inc. | -192.15 Million USD | -77.638% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -501.448% |
| Cassava Sciences, Inc. | -95.68 Million USD | -256.732% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -668.162% |
| Precision BioSciences, Inc. | -32.04 Million USD | -965.308% |
| Dyadic International, Inc. | -8.22 Million USD | -4047.714% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3284.355% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -117201.031% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1066.676% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -178.636% |
| IGM Biosciences, Inc. | -253.35 Million USD | -34.729% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -218.708% |
| Acelyrin, Inc. | -381.52 Million USD | 10.531% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -574.97% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 435.551% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1614.239% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1312.505% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -117.148% |
| Senti Biosciences, Inc. | -61.33 Million USD | -456.518% |
| Mesoblast Limited | -61.33 Million USD | -456.564% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -138.368% |
| ChromaDex Corporation | -3.89 Million USD | -8665.948% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7024.041% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -4870.093% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 138176.014% |
| Seer, Inc. | -97.88 Million USD | -248.721% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1338.155% |
| Novavax, Inc. | -487.39 Million USD | 29.965% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -15072.828% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -98.193% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -554.572% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -51.542% |
| Celcuity Inc. | -58.3 Million USD | -485.399% |
| ContextLogic Inc. | -324 Million USD | -5.354% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -114.617% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -341.341% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 123.55% |
| Amarin Corporation plc | -50.9 Million USD | -570.601% |
| AnaptysBio, Inc. | -143.16 Million USD | -138.43% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1105.701% |
| Aptorum Group Limited | -9.59 Million USD | -3456.059% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -45.214% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -94.309% |
| Ardelyx, Inc. | -55.35 Million USD | -516.66% |
| Celularity Inc. | -183.94 Million USD | -85.569% |
| Omeros Corporation | -163.61 Million USD | -108.634% |
| Humacyte, Inc. | -96.45 Million USD | -253.88% |
| Immunocore Holdings plc | -59.64 Million USD | -472.258% |
| IO Biotech, Inc. | -91.22 Million USD | -274.168% |
| GT Biopharma, Inc. | 5.97 Million USD | 5809.082% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -366.103% |
| Summit Therapeutics Inc. | 1 Million USD | 34200.5% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1004.537% |
| Pulmatrix, Inc. | -12.64 Million USD | -2599.241% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 32.582% |
| Evogene Ltd. | -23.2 Million USD | -1371.065% |
| CorMedix Inc. | -48.88 Million USD | -598.234% |
| BioLineRx Ltd. | -57.06 Million USD | -498.212% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -951.816% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1010.429% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -3.332% |
| scPharmaceuticals Inc. | -46.06 Million USD | -641.074% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -214.628% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 415.116% |
| NLS Pharmaceutics AG | -11.79 Million USD | -2793.828% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1315.674% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -129.66% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2400.154% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1237.615% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -203.948% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -315.096% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -494.929% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1816.632% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1011.821% |
| bluebird bio, Inc. | -167.16 Million USD | -104.202% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 210.011% |
| DBV Technologies S.A. | -85.98 Million USD | -296.997% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -46.189% |
| Galecto, Inc. | -37.51 Million USD | -809.795% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -922.423% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -620.656% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -65.146% |
| GlycoMimetics, Inc. | -39.12 Million USD | -772.517% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -50.086% |
| ADMA Biologics, Inc. | 5.12 Million USD | 6766.914% |
| Clene Inc. | -43.24 Million USD | -689.404% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -13.947% |
| Aptose Biosciences Inc. | -52.26 Million USD | -553.069% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -216.814% |
| Soligenix, Inc. | -7.85 Million USD | -4246.779% |
| Century Therapeutics, Inc. | -121.2 Million USD | -181.62% |
| Kura Oncology, Inc. | -164.95 Million USD | -106.933% |
| Surrozen, Inc. | -41.13 Million USD | -729.9% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -326.16% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -35540.817% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -7821.699% |
| Autolus Therapeutics plc | -156.77 Million USD | -117.737% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -303.211% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1612.381% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -203.327% |
| GRI Bio, Inc. | -10.89 Million USD | -3032.189% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -7459.069% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -380.607% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -228.875% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -795.141% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2126.522% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -4049.412% |
| Jaguar Health, Inc. | -33.13 Million USD | -930.292% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2068.207% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -500.486% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1380.38% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -28.327% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -76.007% |
| Verastem, Inc. | -83.16 Million USD | -310.439% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -115.73% |
| Histogen Inc. | -10.5 Million USD | -3149.986% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2290.427% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -403.26% |
| Surrozen, Inc. | -41.13 Million USD | -729.9% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2205.457% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10643879.233% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -3993.857% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -105.548% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -592.969% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2167.321% |
| Kronos Bio, Inc. | -121.83 Million USD | -180.182% |
| Turnstone Biologics Corp. | -56.23 Million USD | -507.01% |
| Synaptogenix, Inc. | -8.3 Million USD | -4008.886% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2125.347% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -106238.318% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -441.415% |
| Exelixis, Inc. | 196.6 Million USD | 273.623% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -141.389% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 31.071% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -425.269% |
| ESSA Pharma Inc. | -26.45 Million USD | -1190.274% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -8433.765% |
| Avid Bioservices, Inc. | -11.48 Million USD | -2873.138% |
| Insmed Incorporated | -654.73 Million USD | 47.865% |
| MediWound Ltd. | -4.89 Million USD | -6876.211% |
| OmniAb, Inc. | -49.73 Million USD | -586.385% |
| Alector, Inc. | -142.89 Million USD | -138.884% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -299.544% |
| Zai Lab Limited | -366.57 Million USD | 6.882% |
| AlloVir, Inc. | -190.14 Million USD | -79.518% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -17.448% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -211.027% |
| Aura Biosciences, Inc. | -83.69 Million USD | -307.84% |
| Immunic, Inc. | -99.11 Million USD | -244.404% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -159.244% |
| Veracyte, Inc. | -49.4 Million USD | -590.858% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -4732.239% |
| FibroGen, Inc. | -261.4 Million USD | -30.581% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2963.872% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 493.201% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -4775.446% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1723.735% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1242.719% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 955.718% |
| Fortrea Holdings Inc. | 167.3 Million USD | 304.032% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -154.205% |
| XBiotech Inc. | -35.76 Million USD | -854.387% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -425.269% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -124.309% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 64626.654% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -423.136% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -226.788% |
| Agenus Inc. | -145.92 Million USD | -133.92% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1229.643% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -735.261% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 33.906% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -509.318% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -193.416% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1439.706% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -179.556% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -6077.595% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1244.305% |
| Lantern Pharma Inc. | -15.78 Million USD | -2062.239% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Ainos, Inc. | -8.77 Million USD | -3790.826% |
| Pluri Inc. | -20.22 Million USD | -1587.743% |
| Prothena Corporation plc | -190.1 Million USD | -79.554% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -166.265% |
| Rallybio Corporation | -72.37 Million USD | -371.648% |
| Kodiak Sciences Inc. | -259.02 Million USD | -31.782% |
| Cue Biopharma, Inc. | -46.05 Million USD | -641.219% |
| MeiraGTx Holdings plc | -57.05 Million USD | -498.307% |
| Annexon, Inc. | -141.57 Million USD | -141.106% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -431.725% |
| Moderna, Inc. | -3.28 Billion USD | 89.603% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1662.059% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1300.969% |
| Blueprint Medicines Corporation | -474.61 Million USD | 28.079% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2015.478% |
| CalciMedica, Inc. | -34.18 Million USD | -898.409% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -148.996% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -102.638% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -480.619% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -35.245% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -935.449% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -237.248% |
| Nutriband Inc. | -5.12 Million USD | -6564.601% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -688.838% |
| Vor Biopharma Inc. | -114.37 Million USD | -198.455% |
| Roivant Sciences Ltd. | -996.51 Million USD | 65.746% |
| Alkermes plc | 495.04 Million USD | 168.952% |
| ProKidney Corp. | -147.66 Million USD | -131.156% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -428.932% |
| Arcellx, Inc. | -64.14 Million USD | -432.147% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 39.635% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -205.433% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -168883.168% |
| Atai Life Sciences N.V. | -36.31 Million USD | -840.062% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -329.274% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -319.793% |
| MediciNova, Inc. | -9.87 Million USD | -3354.93% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -171.036% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -22207.266% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1179.947% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -51.715% |
| Biomea Fusion, Inc. | -124.62 Million USD | -173.909% |
| RenovoRx, Inc. | -11.39 Million USD | -2896.892% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -79.336% |
| Geron Corporation | -174.78 Million USD | -95.298% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1036.873% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -218.664% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -46.202% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1393.529% |
| Royalty Pharma plc | 1.88 Billion USD | 118.087% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -64.238% |
| Imunon, Inc. | -19.87 Million USD | -1617.181% |
| BioAtla, Inc. | -122.24 Million USD | -179.24% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -13.671% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -723.572% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -105.531% |
| Structure Therapeutics Inc. | -102.45 Million USD | -233.154% |
| 89bio, Inc. | -134.46 Million USD | -153.859% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -243.912% |
| aTyr Pharma, Inc. | -52.17 Million USD | -554.195% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -307.261% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -45.523% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4144.383% |
| Akari Therapeutics, Plc | -16.8 Million USD | -1931.58% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 180987.73% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 175.528% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -108.82% |
| Liquidia Corporation | -70.05 Million USD | -387.282% |
| Entera Bio Ltd. | -8.8 Million USD | -3777.169% |
| GH Research PLC | -41.15 Million USD | -729.456% |
| Vericel Corporation | 2.86 Million USD | 12018.506% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -380.864% |
| Xencor, Inc. | -125.87 Million USD | -171.181% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -23828.162% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2126.522% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1593.385% |
| Vaxcyte, Inc. | -464.88 Million USD | 26.574% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -62.15% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3019.594% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5243.028% |
| Portage Biotech Inc. | -18.19 Million USD | -1775.631% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -22207.266% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -226.385% |
| OncoCyte Corporation | -23.12 Million USD | -1376.218% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -2920.664% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -2879.408% |
| Purple Biotech Ltd. | -22.22 Million USD | -1435.865% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1086.218% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1078.559% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -102.623% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -5225.211% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1056.948% |
| United Therapeutics Corporation | 1.38 Billion USD | 124.614% |
| HilleVax, Inc. | -132.46 Million USD | -157.686% |
| Silo Pharma, Inc. | -3.62 Million USD | -9313.289% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -5480.699% |
| Pharming Group N.V. | 9.87 Million USD | 3555.968% |
| Tharimmune, Inc. | -9.3 Million USD | -3569.366% |
| Genprex, Inc. | -31.06 Million USD | -998.969% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -306.437% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -82.026% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -334.874% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -44578.796% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 226300.763% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2167744.648% |
| Savara Inc. | -59.13 Million USD | -477.251% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1593.269% |
| Curis, Inc. | -45.13 Million USD | -656.211% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2147.006% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1176.824% |
| BeiGene, Ltd. | -1.12 Billion USD | 69.648% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -277.846% |
| Erasca, Inc. | -121.31 Million USD | -181.383% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7487.564% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -7487.564% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -701.112% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -5943.661% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -470.317% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -145.513% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -65.815% |
| Adicet Bio, Inc. | -136.53 Million USD | -150.006% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -270.71% |
| Aditxt, Inc. | -25.45 Million USD | -1240.822% |
| Adagene Inc. | -14.95 Million USD | -2183.131% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4569.513% |
| Quantum-Si incorporated | -91.8 Million USD | -271.82% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 369.935% |
| Compugen Ltd. | -12.51 Million USD | -2627.277% |
| Generation Bio Co. | -133.3 Million USD | -156.074% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -311.112% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -296.808% |
| Invivyd, Inc. | -196.61 Million USD | -73.611% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 8.768% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3580.36% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1357.074% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3218.872% |
| 2seventy bio, Inc. | -206.41 Million USD | -65.366% |
| Instil Bio, Inc. | -146.12 Million USD | -133.603% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1383.534% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -7893.409% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1179.947% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -829.355% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 7051.696% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -115.491% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 50.118% |
| Evaxion Biotech A/S | -21.4 Million USD | -1494.851% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -413.959% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -56.819% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -328.87% |
| Cingulate Inc. | -22.95 Million USD | -1387.215% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -4475.07% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -815.554% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -484.777% |
| Clearmind Medicine Inc. | -8.71 Million USD | -3818.715% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -359.156% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13881.488% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -238.546% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 10.165% |
| ImmunityBio, Inc. | -436.18 Million USD | 21.742% |
| Korro Bio, Inc. | -80.9 Million USD | -321.915% |
| Kineta, Inc. | -15.71 Million USD | -2072.241% |
| BioVie Inc. | -31.95 Million USD | -968.369% |
| Codexis, Inc. | -49.28 Million USD | -592.624% |
| Celularity Inc. | -183.94 Million USD | -85.569% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2086.293% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -54.1% |
| Virax Biolabs Group Limited | -6.6 Million USD | -5064.754% |
| Cibus, Inc. | -314.58 Million USD | -8.507% |
| IN8bio, Inc. | -28.5 Million USD | -1097.537% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -203.152% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1121.055% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -48.405% |
| Eyenovia, Inc. | -24.1 Million USD | -1316.019% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 862.205% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -105253.704% |
| Elevation Oncology, Inc. | -41.46 Million USD | -723.175% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -362.503% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -658.311% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -176.447% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1005.323% |
| Moolec Science SA | -52.07 Million USD | -555.482% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -561.446% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -744.56% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -185.423% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -604.198% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3560.84% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1545.774% |
| Humacyte, Inc. | -96.45 Million USD | -253.88% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -332.768% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 8524.136% |
| Genelux Corporation | -24.16 Million USD | -1312.564% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -909.899% |
| Notable Labs, Ltd. | -14.4 Million USD | -2270.458% |
| Immunovant, Inc. | -269.97 Million USD | -26.435% |
| Quantum-Si incorporated | -91.8 Million USD | -271.82% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1667.899% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -234.614% |
| Acasti Pharma Inc. | -11.3 Million USD | -2920.494% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1433.916% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -821.809% |
| PepGen Inc. | -83.58 Million USD | -308.397% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1390.789% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -7053.497% |
| Immuneering Corporation | -58.06 Million USD | -487.911% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 10643879.233% |
| Belite Bio, Inc | -31.52 Million USD | -982.641% |
| XOMA Corporation | -39.36 Million USD | -767.197% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -406.095% |
| Bionomics Limited | -9.83 Million USD | -3370.023% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -886.378% |
| uniQure N.V. | -253.1 Million USD | -34.866% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4569.513% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -163.58% |
| Forte Biosciences, Inc. | -32.47 Million USD | -951.039% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4140.074% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1109.632% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -105253.704% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -2963.872% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2046.695% |
| Altimmune, Inc. | -87.93 Million USD | -288.18% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -179.233% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -886.378% |
| Peak Bio, Inc. | -1356.23 USD | -25168639.816% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -602.387% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1417.768% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -40.876% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1095.901% |
| Zura Bio Limited | -60.56 Million USD | -463.621% |
| PolyPid Ltd. | -20.26 Million USD | -1584.578% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1095.901% |
| argenx SE | -216.02 Million USD | -58.014% |
| Immunome, Inc. | -28.27 Million USD | -1107.407% |
| Verona Pharma plc | -52.46 Million USD | -550.585% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -260.176% |
| Shattuck Labs, Inc. | -87.61 Million USD | -289.598% |
| CervoMed Inc. | -2.17 Million USD | -15616.658% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2589.246% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -608.569% |
| Moolec Science SA | -52.07 Million USD | -555.482% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -1891.519% |
| Design Therapeutics, Inc. | -66.32 Million USD | -414.657% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -321.482% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -804.228% |
| Achilles Therapeutics plc | -70.44 Million USD | -384.577% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -13881.488% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -515.792% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -575.264% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -422.919% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -530.838% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -652.261% |
| Beam Therapeutics Inc. | -156.47 Million USD | -118.15% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -150.089% |
| AEON Biopharma, Inc. | -48.36 Million USD | -605.829% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -422.215% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -316.621% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2663.93% |
| NeurAxis, Inc. | -6.66 Million USD | -5021.858% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 20.14% |
| Lumos Pharma, Inc. | -36.57 Million USD | -833.404% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 5955.748% |
| Palisade Bio, Inc. | -12.28 Million USD | -2679.464% |
| Nutriband Inc. | -5.12 Million USD | -6564.601% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -224.483% |
| Neurogene Inc. | -52.28 Million USD | -552.844% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -3965.579% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -266.968% |
| Athira Pharma, Inc. | -116.7 Million USD | -192.491% |
| HCW Biologics Inc. | -23.57 Million USD | -1347.85% |
| XOMA Corporation | -39.36 Million USD | -767.197% |
| Nektar Therapeutics | -243.1 Million USD | -40.41% |
| Arvinas, Inc. | -394.8 Million USD | 13.54% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 180987.73% |
| Merus N.V. | -149.2 Million USD | -128.773% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -265.115% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -991.958% |
| Rezolute, Inc. | -68.42 Million USD | -398.876% |
| Clene Inc. | -43.24 Million USD | -689.404% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2113.343% |
| BeyondSpring Inc. | -21.54 Million USD | -1484.708% |
| Synlogic, Inc. | -55.16 Million USD | -518.818% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2725.01% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3107.536% |
| Peak Bio, Inc. | -1356.23 USD | -25168639.816% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -951.428% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2006.535% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -188.243% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -7310.204% |
| MannKind Corporation | 15.12 Million USD | 2356.236% |
| Ikena Oncology, Inc. | -74.39 Million USD | -358.817% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2610.601% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1779.274% |
| Gossamer Bio, Inc. | -172.15 Million USD | -98.282% |
| CohBar, Inc. | -12.06 Million USD | -2729.047% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1238.139% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1036.873% |
| Legend Biotech Corporation | -477.87 Million USD | 28.57% |
| Mural Oncology plc | -192.72 Million USD | -77.12% |
| Disc Medicine, Inc. | -91.02 Million USD | -275.002% |
| Champions Oncology, Inc. | -5.05 Million USD | -6653.977% |
| REGENXBIO Inc. | -239.46 Million USD | -42.546% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3084.736% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -512.214% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -780.478% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -202.596% |
| Vaxart, Inc. | -74.72 Million USD | -356.815% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -869.504% |
| Cellectis S.A. | -98.09 Million USD | -247.975% |
| Longeveron Inc. | -20.06 Million USD | -1601.625% |
| Repare Therapeutics Inc. | -114.27 Million USD | -198.711% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 22.279% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -356.272% |
| Revolution Medicines, Inc. | -430.58 Million USD | 20.725% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -5327.667% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1008.662% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -357.63% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 7061.982% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3013.051% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 107.412% |
| Denali Therapeutics Inc. | -179.97 Million USD | -89.665% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -358426.594% |
| Veru Inc. | -89.97 Million USD | -279.376% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1169.983% |
| Cingulate Inc. | -22.95 Million USD | -1387.215% |
| Passage Bio, Inc. | -98.34 Million USD | -247.104% |
| Context Therapeutics Inc. | -25.06 Million USD | -1262.084% |
| Exicure, Inc. | -15.53 Million USD | -2096.705% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -65.65% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -823.156% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -5624.788% |
| Nuvalent, Inc. | -149.49 Million USD | -128.337% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -4097.351% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -297.404% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1031.109% |
| OmniAb, Inc. | -49.73 Million USD | -586.385% |
| Anew Medical, Inc. | -1.3 Million USD | -26140.429% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2660.806% |
| Lipocine Inc. | -16.32 Million USD | -1991.239% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -411.993% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -359.397% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -795.141% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -774.932% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1438.773% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 37.376% |
| Ocugen, Inc. | -64.82 Million USD | -426.549% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -268.744% |
| Q32 Bio Inc. | -86.5 Million USD | -294.611% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -1916.577% |
| Alumis Inc. Common Stock | -156.89 Million USD | -117.57% |
| Equillium, Inc. | -12.13 Million USD | -2712.21% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -483.777% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4219.005% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1709.8% |
| Dominari Holdings Inc. | -22.44 Million USD | -1421.15% |
| Edesa Biotech, Inc. | -8.19 Million USD | -4067.767% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1243.247% |
| Bio-Techne Corporation | 326.66 Million USD | 204.495% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 11.307% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 257.746% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -160.355% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -811.934% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -125.906% |
| Nkarta, Inc. | -120.48 Million USD | -183.319% |
| BioCardia, Inc. | -11.56 Million USD | -2852.82% |
| Iterum Therapeutics plc | -34.58 Million USD | -887.12% |